{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:36:39Z","timestamp":1791606999302,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RC-2023- 2778936"],"award-info":[{"award-number":["RC-2023- 2778936"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clgc.2025.102348","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:35:28Z","timestamp":1743968128000},"page":"102348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["PSMA-Targeted Biopsy With Fusion Guidance for Detecting Clinically Significant Prostate Cancer in Men With Negative MRI-Feasibility and Diagnostic Performance of a Pilot Single-Center Prospective Study"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7321-1536","authenticated-orcid":false,"given":"Lorenzo","family":"Bianchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2693-3039","authenticated-orcid":false,"given":"Danilo","family":"Cangemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5443-4301","authenticated-orcid":false,"given":"Andrea","family":"Farolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina Maria Paola","family":"Sgro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Di","family":"Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Castellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Gaudiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beniamino","family":"Corcioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Giunchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Degiovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Pirelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Mignogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Rotaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Mottaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Droghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Ragni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Romei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mosconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Schiavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Brunocilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10071","key":"10.1016\/j.clgc.2025.102348_bib0001","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.clgc.2025.102348_bib0002","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"New Engl J Med"},{"issue":"3","key":"10.1016\/j.clgc.2025.102348_bib0003","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.eururo.2020.03.048","article-title":"Negative predictive value of multiparametric Magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and Data System era: a systematic review and meta-analysis","volume":"78","author":"Sathianathen","year":"2020","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102348_bib0004","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41391-017-0024-7","article-title":"Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer","volume":"21","author":"Nordstr\u00f6m","year":"2018","journal-title":"Prostat Cancer Prostat Dis"},{"issue":"2","key":"10.1016\/j.clgc.2025.102348_bib0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.euf.2022.10.002","article-title":"Prostate-specific antigen density cutoff of 0.15 ng\/ml\/cc to propose Prostate biopsies to patients with negative Magnetic resonance imaging: efficient threshold or legacy of the past?","volume":"9","author":"Pellegrino","year":"2023","journal-title":"Eur Urol Focus"},{"issue":"4","key":"10.1016\/j.clgc.2025.102348_bib0006","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.euo.2022.04.006","article-title":"Diagnostic performance of prostate-specific membrane antigen positron emission tomography-targeted biopsy for detection of clinically significant prostate cancer: a systematic review and meta-analysis","volume":"5","author":"Kawada","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.clgc.2025.102348_bib0007","first-page":"1","article-title":"A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET\/CT in the initial staging of prostate cancer","author":"Mari","year":"2024","journal-title":"Prostat Cancer Prostat Dis"},{"issue":"10231","key":"10.1016\/j.clgc.2025.102348_bib0008","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clgc.2025.102348_bib0009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.euo.2021.12.002","article-title":"Multicenter external validation of a nomogram for predicting positive prostate-specific membrane antigen\/positron emission tomography scan in patients with prostate cancer recurrence","volume":"6","author":"Bianchi","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"13","key":"10.1016\/j.clgc.2025.102348_bib0010","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1158\/1078-0432.CCR-20-4573","article-title":"Diagnostic performance of 18F-DCFPyL-PET\/CT in men with biochemically recurrent prostate cancer: results from the CONDOR Phase III, Multicenter study","volume":"27","author":"Morris","year":"2021","journal-title":"Clin Ca Res"},{"issue":"4","key":"10.1016\/j.clgc.2025.102348_bib0011","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"Perera","year":"2020","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102348_bib0012","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.eururo.2018.01.006","article-title":"Efficacy, predictive factors, and prediction nomograms for 68Ga-labeled prostate-specific membrane antigen\u2013ligand positron-emission tomography\/computed tomography in early biochemical recurrent prostate cancer after radical prostatectomy","volume":"73","author":"Rauscher","year":"2018","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.clgc.2025.102348_bib0013","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3390\/cancers16101833","article-title":"PSMA-targeted therapy: advancements in detection and treatment modalities with Dr. Scott T. Tagawa","volume":"16","author":"Cortiana","year":"2024","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.clgc.2025.102348_bib0014","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.eururo.2023.11.018","article-title":"Prostate-specific membrane antigen\u2013Targeted therapies for Prostate cancer: towards improving therapeutic outcomes","volume":"85","author":"Corpetti","year":"2024","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102348_bib0015","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","article-title":"PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions","volume":"40","author":"Afshar-Oromieh","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.clgc.2025.102348_bib0016","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2967\/jnumed.117.195172","article-title":"Immunohistochemical validation of PSMA expression measured by 68Ga-PSMA PET\/CT in primary prostate cancer","volume":"59","author":"Woythal","year":"2018","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.clgc.2025.102348_bib0017","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","volume":"80","author":"Emmett","year":"2021","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102348_bib0018","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.euo.2023.04.006","article-title":"Head-to-Head comparison of 18F-PSMA-1007 positron emission tomography\/computed tomography and multiparametric magnetic resonance imaging with whole-mount histopathology as reference in localisation and staging of primary prostate cancer","volume":"6","author":"Exterkate","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102348_bib0019","article-title":"Fluorine-18-labelled prostate-specific membrane antigen positron emission tomography\/computed tomography or magnetic resonance imaging to diagnose and localise prostate cancer. A prospective single-arm paired comparison (PEDAL)","volume":"7","author":"Wong","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102348_bib0020","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4081\/aiua.2022.3.274","article-title":"Targeted prostate biopsy: 68Ga-PSMA PET\/CT vs. mpMRI in the diagnosis of prostate cancer","volume":"94","author":"Pepe","year":"2022","journal-title":"Archivio Italiano di Urologia e Andrologia"},{"issue":"0","key":"10.1016\/j.clgc.2025.102348_bib0021","article-title":"PSMA PET-targeted biopsy for prostate cancer diagnosis: initial experience from a multicenter cohort","volume":"0","author":"Checcucci","year":"2024","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.clgc.2025.102348_bib0022","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102348_bib0023","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102348_bib0024","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","article-title":"68Ga-PSMA PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0","volume":"44","author":"Fendler","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.clgc.2025.102348_bib0025","first-page":"1644","article-title":"The PRIMARY score: using intraprostatic 68Ga-PSMA PET\/CT patterns to optimize prostate cancer diagnosis","volume":"63","author":"Emmett","year":"2022","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.clgc.2025.102348_bib0026","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","article-title":"Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE V2)","volume":"83","author":"Seifert","year":"2023","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102348_bib0027","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/cancers15061716","article-title":"Histology and PSMA expression on immunohistochemistry in high-risk prostate cancer patients: comparison with 68Ga-PSMA PET\/CT features in primary staging","volume":"15","author":"Vetrone","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.clgc.2025.102348_bib0028","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on prostate cancer-2024 update. Part I: Screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102348_bib0029","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/JU.0000000000003492","article-title":"Early detection of prostate cancer: AUA\/SUO guideline Part II: Considerations for a prostate biopsy","volume":"210","author":"Wei","year":"2023","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102348_bib0030","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.euf.2017.02.017","article-title":"Prognostic biomarkers used for localised prostate cancer management: a systematic review","volume":"4","author":"Lamy","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.clgc.2025.102348_bib0031","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.critrevonc.2017.11.007","article-title":"Biomarkers in prostate cancer \u2013 Current clinical utility and future perspectives","volume":"120","author":"Kretschmer","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102348_bib0032","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00345-022-04243-5","article-title":"Investigating PSMA-PET\/CT to resolve prostate MRI PIRADS4-5 and negative biopsy discordance","volume":"41","author":"Wong","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2025.102348_bib0033","first-page":"1","article-title":"A cost-effectiveness study of PSMA-PET\/CT for the detection of clinically significant prostate cancer","author":"Priv\u00e9","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.clgc.2025.102348_bib0034","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.euf.2020.03.004","article-title":"Prospective evaluation of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography\/computed tomography in primary prostate cancer diagnosis","volume":"7","author":"Lopci","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.clgc.2025.102348_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1324631","article-title":"Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection","volume":"14","author":"Droghetti","year":"2024","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102348_bib0036","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.euo.2023.11.008","volume":"7","author":"Buteau","year":"2024","journal-title":"Eur Urol Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T07:25:32Z","timestamp":1754551532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325000497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1558767325000497"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102348","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PSMA-Targeted Biopsy With Fusion Guidance for Detecting Clinically Significant Prostate Cancer in Men With Negative MRI-Feasibility and Diagnostic Performance of a Pilot Single-Center Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102348"}}